Jennifer A. Byrne
Jennifer A. Byrne
NSW Health Pathology, University of Sydney
Verified email at - Homepage
Cited by
Cited by
The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity
EYM Sum, B Peng, X Yu, J Chen, J Byrne, GJ Lindeman, JE Visvader
Journal of Biological Chemistry 277 (10), 7849-7856, 2002
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer
MA Rubin, S Varambally, R Beroukhim, SA Tomlins, DR Rhodes, PL Paris, ...
Cancer research 64 (11), 3814-3822, 2004
Improving the peer review of narrative literature reviews
JA Byrne
Research Integrity and Peer Review 1, 12, 2016
A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence
JA Byrne, C Tomasetto, JM Garnier, N Rouyer, MG Mattei, JP Bellocq, ...
Cancer research 55 (13), 2896-2903, 1995
Proteomic screening of glutamatergic mouse brain synaptosomes isolated by fluorescence activated sorting
C Biesemann, M Grřnborg, E Luquet, SP Wichert, V Bernard, SR Bungers, ...
The EMBO journal 33 (2), 157-170, 2014
MAL2, a novel raft protein of the MAL family, is an essential component of the machinery for transcytosis in hepatoma HepG2 cells
MC de Marco, F Martín-Belmonte, L Kremer, JP Albar, I Correas, ...
The Journal of cell biology 159 (1), 37-44, 2002
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
DR Carter, J Murray, BB Cheung, L Gamble, J Koach, J Tsang, S Sutton, ...
Science translational medicine 7 (312), 312ra176-312ra176, 2015
Definition of the Tumor Protein D52 (TPD52) Gene Family through Cloning ofD52Homologues in Human (hD53) and Mouse (mD52)
JA Byrne, MG Mattei, P Basset
Genomics 35 (3), 523-532, 1996
Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer
JA Byrne, RL Balleine, MS Fejzo, J Mercieca, YE Chiew, Y Livnat, ...
International journal of cancer 117 (6), 1049-1054, 2005
The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma
RL Balleine, MS Fejzo, P Sathasivam, P Basset, CL Clarke, JA Byrne
Genes, Chromosomes and Cancer 29 (1), 48-57, 2000
The tumor protein D52 family: many pieces, many puzzles
R Boutros, S Fanayan, M Shehata, JA Byrne
Biochemical and biophysical research communications 325 (4), 1115-1121, 2004
Digital magic, or the dark arts of the 21st century—how can journals and peer reviewers detect manuscripts and publications from paper mills?
JA Byrne, J Christopher
FEBS letters 594 (4), 583-589, 2020
Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system
SHD Wilson, AM Bailey, CR Nourse, MG Mattei, JA Byrne
Genomics 76 (1-3), 81-88, 2001
The formin INF2 regulates basolateral-to-apical transcytosis and lumen formation in association with Cdc42 and MAL2
R Madrid, JF Aranda, AE Rodríguez-Fraticelli, L Ventimiglia, ...
Developmental cell 18 (5), 814-827, 2010
Identification of homo-and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system
JA Byrne, CR Nourse, P Basset, P Gunning
Oncogene 16 (7), 873-881, 1998
Short-term expansion of receptive fields in rat primary somatosensory cortex after hindpaw digit denervation
JA Byrne, MB Calford
Brain research 565 (2), 218-224, 1991
Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52
JD Lewis, LA Payton, JG Whitford, JA Byrne, DI Smith, LB Yang, RK Bright
Molecular cancer research 5 (2), 133-144, 2007
Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52
M Shehata, I Bieche, R Boutros, J Weidenhofer, S Fanayan, L Spalding, ...
Clinical Cancer Research 14 (16), 5050-5060, 2008
Overexpressed oncogenic tumor-self antigens: New vaccine targets
RK Bright, JD Bright, JA Byrne
Human vaccines & immunotherapeutics 10 (11), 3297-3305, 2014
Molecular profiling of childhood cancer: biomarkers and novel therapies
F Saletta, C Wadham, DS Ziegler, GM Marshall, M Haber, G McCowage, ...
BBA clinical 1, 59-77, 2014
The system can't perform the operation now. Try again later.
Articles 1–20